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In Brief
T cell activation is initiated by Src kinases, which are inhibited by another kinase, Csk. Davidson et al. show that the transmembrane adaptor PAG plays a critical role in the recruitment of Csk toward Src kinases. This function is seen in effector T cells but not in naive T cells.
INTRODUCTION
T cell activation results from engagement of the T cell receptor (TCR) by antigen peptides and major histocompatibility complex (MHC) molecules displayed by antigen-presenting cells (APCs) (Weiss and Littman, 1994) . TCR signaling is instigated by protein tyrosine phosphorylation, which is initiated by Src family enzymes, a group of intracellular protein tyrosine kinases (PTKs) associated with the plasma membrane inner leaflet. The Src kinases in T cells, Lck and Fyn, mediate this effect largely by phosphorylating immunoreceptor tyrosine-based activation motifs (ITAMs) in TCR-associated CD3 and z chains. ITAM tyrosine phosphorylation enables recruitment of another PTK, ZAP-70, which phosphorylates other proteins, leading to effector functions.
The enzymatic activity of Src kinases is regulated by tyrosine phosphorylation (Veillette et al., 2002) . Phosphorylation of a tyrosine (Y) in the kinase domain (Y394 in Lck, Y417 in Fyn) leads to activation. This is mediated by autophosphorylation and reversed by protein tyrosine phosphatases (PTPs) such as PTPN22 and SHP-1. Defects in these phosphatases, in particular PTPN22, are linked to autoimmune diseases in humans (Rhee and Veillette, 2012; Stanford and Bottini, 2014) . In contrast, phosphorylation of a carboxyl-terminal tyrosine (Y505 in Lck, Y528 in Fyn) inactivates Src kinases. This is mediated by another PTK, Csk, and is reversed by the transmembrane PTP CD45. Although Src kinases are membrane-bound, Csk is cytoplasmic. Thus, Csk needs to bind membrane-associated molecules to be near Src kinases.
A strong candidate for recruiting Csk to the plasma membrane is the transmembrane adaptor phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), also known as Cbp (Brdicka et al., 2000; Hrdinka and Horejsi, 2014; Kawabuchi et al., 2000; Simeoni et al., 2008) . Membrane-bound PAG is also targeted to lipid rafts, where large pools of Src kinases reside. PAG is prominently tyrosine-phosphorylated in unstimulated T cells (Brdicka et al., 2000; Davidson et al., 2003) . This phosphorylation enables binding to Csk by way of tyrosine 314 (Y314) of PAG and the Src homology 2 (SH2) domain of Csk. Upon TCR stimulation, PAG is dephosphorylated and dissociates from Csk (Brdicka et al., 2000; Davidson et al., 2003; Torgersen et al., 2001 ). This event is presumed to alleviate the suppressive effect of Csk on Src kinases.
In support of the inhibitory role of Csk in TCR signaling, pharmacological inhibition of Csk in mature T cells augmented T cell activation (Manz et al., 2015) . Conversely, Csk overexpression in a T cell line suppressed T cell activation (Chow et al., 1993; Manz et al., 2015) . Furthermore, Csk-deficient (knockout [KO] ) mice exhibited severe T cell developmental abnormalities (Schmedt et al., 1998; Tan et al., 2014) . Although it had been presumed that PAG mediates membrane recruitment of Csk in T cells, two groups reported that PAG KO mice had no overt T cell phenotype (Dobenecker et al., 2005; Xu et al., 2005) . This observation raised the possibility that PAG is not responsible for membrane recruitment of Csk or, alternatively, that other Csk-binding molecules provide this function in the absence of PAG.
To resolve these matters, we further evaluated T cell functions of PAG-deficient mice. As reported (Dobenecker et al., 2005; Xu et al., 2005) , PAG KO mice displayed no obvious alterations in T cell development and had unaltered T cell activation responses when freshly isolated (naive) T cells were analyzed. In contrast, these mice displayed increased activation responses in vitro and in vivo when previously activated (effector) T cells were assessed. In the absence of PAG, Csk became more extensively associated with alternative Csk-interacting proteins (namely, PTPN22 and Dok adaptors), which cooperated with PAG to suppress activation of previously activated T cells. Last, unlike mice lacking PAG, PTPN22, or Dok adaptors, mice genetically deficient for Cbl ubiquitin ligases had augmented activation responses in freshly isolated T cells, suggesting that a distinct set of inhibitory effectors, including the Cbl proteins, is controlling TCR signaling in naive T cells.
RESULTS

PAG-Deficient Mice Display Augmented Responses in
Previously Activated, but Not in Freshly Isolated, T Cells To elucidate the role of PAG in T cells, the effect of PAG deficiency was examined using a previously described PAG KO mouse ( Figure 1A ; Lindquist et al., 2011; Yang and Seed, 2003) . As reported, PAG KO mice had no alterations in the numbers of various subsets of thymocytes compared with wild-type mice (Table S1 ; Dobenecker et al., 2005; Xu et al., 2005) . They also had no significant change in the numbers of all T cell subsets tested (Table S1 ). Levels of antibodies and germinal center B cells were also not affected (Table S2) . Similar findings were made with young (1.5-to 3-month-old) and aged (9-to 13-month-old) mice (Tables S1 and S2) .
To study functional responses, we focused on CD4 + T cells.
Freshly isolated (ex vivo) PAG KO T cells stimulated with antibodies against CD3 (anti-CD3) alone or anti-CD3 plus anti-CD28 showed normal proliferation and cytokine production compared with wild-type T cells ( Figure S1A ). In striking contrast, previously activated PAG KO T cells (i.e., cells that have encountered a previous stimulation) demonstrated increased thymidine incorporation as well as augmented secretion of interferon (IFN) g, interleukin-2 (IL-2), and IL-4 in comparison with wildtype T cells ( Figure 1B ). These effects were not seen with phorbol myristate acetate (PMA) and ionomycin (P+I), which trigger activation by bypassing proximal TCR signaling ( Figure 1B ). The superantigen staphylococcal enterotoxin B (SEB), in the presence of APCs, triggers activation of Vb8.2 + CD4 + T cells.
Although freshly isolated PAG KO T cells did not have altered responses to SEB and APCs ( Figure S1B ), previously activated PAG KO T cells showed significantly augmented proliferation and IFN-g production compared with wild-type T cells (Figure 1C) . No difference in the abundance of Vb8.2 + CD4 + T cells existed between wild-type and PAG KO mice (Table S1) . Likewise, when PAG KO mice were bred with MHC class II-restricted pigeon cytochrome c (PCC)-specific TCR transgenic mice, freshly isolated PAG KO T cells did not show an altered ability to respond to PCC peptide and APCs ( Figure S1C ). However, previously activated PAG KO T cells displayed increased IFN-g secretion and, to a lesser extent, thymidine incorporation in comparison with wild-type T cells ( Figure 1D ; Figure S1D ). The effect of PAG deficiency was also ascertained in an ex vivo antigen re-stimulation assay. Mice were immunized in the foot pad with ovalbumin (OVA) in the presence of adjuvant. After 9 days, CD4 + T cells from draining lymph nodes were re-stimulated in vitro with OVA and APCs. T cells from PAG KO mice displayed markedly increased OVA-induced proliferation and IFN-g production ( Figure 1E ; Figure S1E ).
To confirm that the increased responses of PAG KO T cells were due to PAG deficiency, PAG expression was reconstituted using retrovirus-mediated gene transfer of either wild-type PAG or a PAG mutant unable to bind Csk (PAG tyrosine 314 to phenylalanine 314 [Y314F]). The levels of expression of the two proteins were similar ( Figure 1F ). Wild-type PAG, but not PAG Y314F, corrected the enhanced SEB-induced proliferation and IFN-g production of PAG KO T cells ( Figure 1G ; Figure S1F ).
Hence, loss of PAG in CD4 + T cells augmented antigen receptor-mediated responses in previously activated, but not in freshly isolated, T cells. This effect was corrected by wild-type PAG but not by a PAG mutant unable to bind Csk.
Increased TCR Signaling in Previously Activated PAG-Deficient T Cells
The effect of PAG deficiency on TCR signaling was assessed. Freshly isolated PAG KO T cells showed no alteration of TCR-triggered protein tyrosine phosphorylation compared with wild-type T cells (Figure 2A ). This was observed whether cells were triggered with anti-CD3 or anti-TCR (data not shown). There was also no change in the activation of Erk, Akt, and calcium fluxes ( Figures S2A and S2B ). In contrast, previously activated PAG KO T cells demonstrated prominently enhanced TCR-induced protein tyrosine phosphorylation compared with wild-type T cells (Figure 2A ). This effect involved all TCR-regulated substrates, including ITAMs and ZAP-70, as well as Lck and Fyn, which showed augmented phosphorylation at their activating tyrosine (Y394 for Lck and Y417 for Fyn) (Figures 2A and 2B;  Figure S2C ). The identity of Lck and Fyn in the phospho-Src kinase immunoblots was confirmed by immunodepletion ( Figure S2D) . Surprisingly, little or no appreciable effect was seen on phosphorylation of the inhibitory tyrosine of Lck, Y505 ( Figure 2B ). Previously activated PAG KO T cells also showed increased TCR-triggered calcium fluxes (Figure 2C) . Nevertheless, they exhibited minimal or no increase in activation of Erk, Akt, c-Jun N-terminal kinase (JNK), PKC-q, p38 kinase, and inhibitor of kBa (IkBa) ( Figure 2D ; Figure S2E ). A quantitation of these findings is shown in Figure S2F .
To ensure that the increased TCR-evoked signals in PAG KO mice were due to PAG deficiency, wild-type PAG was re-introduced using retroviral infection ( Figure 2E ). Re-expression of PAG, but not of an empty vector, corrected the augmented TCR-triggered protein tyrosine phosphorylation of PAG KO cells ( Figure 2F ).
Combined, these findings showed that PAG deficiency globally enhanced TCR signaling, including activation of Src kinases. As was the case for functional responses, these effects were observed in previously activated, but not in freshly isolated, T cells.
PAG-Deficient Mice Have Enhanced Susceptibility to Experimental Autoimmune Encephalomyelitis
To validate in vivo the notion that PAG controls the activation of previously activated cells, susceptibility to experimental autoimmune encephalomyelitis (EAE), a model of T cell-dependent autoimmunity, was examined. In this model, mice are immunized with a myelin oligodendrocyte glycoprotein (MOG)-derived peptide. MOG-specific effector CD4 + T cells subsequently migrate to the nervous system, where they are re-activated by (E) Mice (two mice in each group) were immunized with OVA and adjuvant. After 9 days, CD4 + T cells were isolated and re-stimulated with the indicated concentrations of OVA and WT splenocytes or P+I. After 4-5 days (for OVA re-stimulation) or 2 days (for P+I), production of IFN-g was monitored as detailed in (B).
(F and G) CD4 + T cells activated in vitro with anti-CD3 plus anti-CD28 were infected with retroviruses encoding GFP alone or in combination with WT PAG or PAG Y314F. After sorting of GFP-positive cells, expression of PAG was verified by immunoblotting of total cell lysates (F). Responsiveness to SEB was also examined, as detailed in (C) (G). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n > 25 (A), n = 4 (B), n = 6 (C), n = 4 (D), n = 3 (E), and n = 2 (F and G). See also Figure S1 .
endogenous MOG. PAG KO mice were much more susceptible to EAE than wild-type mice ( Figure 3A) . Moreover, after a booster immunization, given at a time when clinical signs of EAE had resolved, PAG KO mice developed the disease again, whereas wild-type mice were tolerant ( Figure 3A ). To confirm that the increased susceptibility to EAE was due to functional differences in CD4 + T cells, an ex vivo antigen re-stimulation assay was performed. Re-stimulation of PAG KO CD4 + T cells with MOG peptide in the presence of APCs resulted in greater thymidine incorporation as well as augmented secretion of IFN-g and IL-17, two cytokines that have a key pathogenic role in EAE ( Figure 3B ; Figure S3A ). Adoptive transfer experiments were also performed. CD4 + T cells were purified from MOG-immunized mice and transferred into RAG-1 KO mice, and their ability to induce EAE was monitored. Mice injected with PAG KO T cells displayed a greater severity of EAE than mice injected with wild-type T cells ( Figure 3C ). The poor induction of EAE by wild-type T cells was not due to lack of functionality because EAE was induced when three times more wild-type T cells were transferred ( Figure 3D ). Therefore, loss of PAG increased the sensitivity of mice to EAE. Moreover, it decreased tolerance of EAE. These effects were T cell-intrinsic.
Increased Resistance to T Cell Anergy in PAG-Deficient Mice
Our previous studies showed that T cells from transgenic mice overexpressing PAG had decreased resistance to anergy was then detected by immunoblotting of total cell lysates with anti (a)-phosphotyrosine (P.tyr). An 8% gel was used to detect overall protein tyrosine phosphorylation (first panel). A 15% gel was used to detect phosphorylated ITAM-containing z chains (p23, p21, and p16) (second panel). Phosphorylated ZAP-70 and total ZAP-70 were also detected (third and fourth panels) by immunoblotting with phospho-specific anti-ZAP-70 and anti-ZAP-70, respectively. The positions of prestained molecular mass markers are shown on the right. (B) Phosphorylation of protein tyrosine kinases in previously activated CD4 + T cells was assessed as detailed for (A) using phospho-specific antibodies.
(C) After loading with Indo-1, previously activated T cells were stimulated with anti-TCR (left) or ionomycin (iono, right). Changes in intracellular calcium were assessed by measuring the ratio between calcium-bound Indo-1 and calcium-free Indo-1 using flow cytometry. The arrow indicates when the stimulus was added.
(D) Same as (B), except that cell lysates were probed by immunoblotting with the indicated antibodies.
(E and F) Previously activated CD4 + T cells were infected with retroviruses encoding GFP alone or in combination with WT PAG. After sorting GFP-positive cells, expression of PAG was verified by immunoblotting of total cell lysates (E). Anti-CD3-induced protein tyrosine phosphorylation was also examined (F). Representative of n = 3 (A), n = 4 (B), n = 2 (C), n = 3 (D), and n = 2 (E and F). See also Figure S2 .
compared to wild-type T cells (Davidson et al., 2007) . However, a role of PAG in anergy had not been supported by earlier studies of PAG KO mice (Dobenecker et al., 2005; Xu et al., 2005) . To clarify the role of PAG in anergy, PAG KO mice were tested in two models of T cell anergy. secretion were monitored. The anergy index is the ratio of thymidine incorporation or IL-2 secretion between cells from PBS-injected and OVA peptide-injected mice. Means with SD of triplicate values are depicted (E). Anergy indices are represented graphically (F). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n = 2 (A), n = 2 (B), n = 2 (C), n = 2 (D), and n = 2 (E and F). See also Figure S3 .
suppressed subsequent T cell responses in wild-type mice. This effect was much weaker in PAG KO mice, as reflected by the lower anergy indices ( Figures 3E and 3F) . Thus, PAG KO mice displayed increased resistance to anergy in the two experimental models tested.
Increased Association of Csk with PTPN22 in PAG-Deficient T Cells
The finding that the alterations of T cell functions in PAG KO mice were milder than those in mice lacking Csk (Schmedt et al., 1998) suggested that compensatory mechanisms might be limiting TCR signaling in PAG KO mice. To address this idea, we tested the effect of PAG deficiency on the expression of various TCR signaling molecules. PAG KO T cells displayed no change in expression of Lck, Fyn, Csk, CD45, PTPN22, SHP-1, or the ubiquitin ligases c-Cbl and Cbl-b compared with wild-type T cells both in freshly isolated and in previously activated T cells ( Figures  4A and 4B ). Of note, however, previously activated T cells displayed 4-to 5-fold higher levels of PTPN22 and 2.0-to 2.5-fold higher levels of Cbl-b than freshly isolated T cells ( Figure 4A ). Moreover, in protein gels, CD45 migrated as a doublet in freshly isolated T cells but as a single species in previously activated T cells, likely reflecting variations in CD45 isoforms (Figures 4A and 4B; Rhee and Veillette, 2012; Zikherman and Weiss, 2008) .
We examined the association of Csk with PTPN22, which cooperates with Csk in inhibition of TCR signaling (Rhee and Veillette, 2012) . In wild-type T cells, Csk was minimally associated with PTPN22 prior to TCR triggering ( Figures 4C and 4D ). This interaction was markedly increased by TCR stimulation. Conversely, Csk was strongly associated with PAG prior to TCR stimulation, and this association was decreased by TCR stimulation ( Figures 4C  and 4D ), as reported previously (Brdicka et al., 2000; Davidson et al., 2003) . In PAG KO T cells, however, the association of Csk with PTPN22 was markedly enhanced (more than 10-fold) in unstimulated cells compared with wild-type T cells ( Figures 4C  and 4D ). This association was not affected by TCR stimulation.
Thus, in PAG-deficient T cells, expression of various components of the TCR signaling machinery was not altered. Nonetheless, the Csk-PTPN22 interaction was constitutively augmented.
PTPN22 Cooperates with PAG to Suppress Effector T Cell Responses
To assess whether PTPN22 might attenuate the effect of PAG deficiency in T cells, mice lacking both PAG and PTPN22 Representative of n = 2-6, depending on protein (A), n = 2 (B), and n = 2 (C).
(PAG PTPN22 double knockout [DKO]) were generated and analyzed in parallel with mice lacking PAG or PTPN22 alone (Figure S4A ). Contrary to PAG KO or PTPN22 KO T cells, freshly isolated PAG PTPN22 DKO T cells displayed a small increase in proliferation and IFN-g production in response to anti-CD3, anti-TCR plus anti-CD28, or SEB compared with wild-type T cells ( Figures  S4B and S4C) . A small increase in TCR-triggered protein tyrosine phosphorylation was also observed ( Figure S4D ). More strikingly, however, when previously activated T cells were studied, PAG PTPN22 DKO cells exhibited markedly enhanced proliferation and IFN-g secretion in response to these stimuli compared with PAG KO or PTPN22 KO cells (Figures 5A and 5B). They also exhibited greater TCR-triggered protein tyrosine phosphorylation and calcium fluxes (Figures 5C and  5D ; Figure S4E ). There was little or no effect on Erk, p38, and Akt ( Figure 5E ; Figure S4E ). In keeping with an earlier report (Hasegawa et al., 2004) , previously activated PTPN22 KO T cells, but not freshly isolated PTPN22 KO T cells, also displayed enhanced TCR-triggered protein tyrosine phosphorylation, calcium fluxes, and effector responses compared with wild-type Figure 2C . (E) Same as in (C), except that total cell lysates were probed by immunoblotting with the indicated antibodies. **p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n = 2 (A), n = 2 (B), n = 3 (C), n = 2 (D), and n = 3 (E). See also Figure S4 .
T cells (Figures 5A-5D ). These changes were analogous to those seen in PAG KO T cells. Therefore, loss of PTPN22 accentuated the effect of PAG deficiency in previously activated CD4 + T cells, seemingly by further enhancing overall TCR-triggered protein tyrosine phosphorylation.
Augmented Tyrosine Phosphorylation of Dok Adaptors in PAG-Deficient T Cells
We noted that previously activated PAG KO T cells exhibited augmented tyrosine phosphorylation of two proteins, p62 and p56, compared with wild-type T cells ( Figure 6A ). These proteins might represent Dok-1 and Dok-2, two inhibitory adaptor molecules associating with Csk and with other inhibitory effectors, such as the lipid phosphatase SHIP-1 and Ras-GTPase activating protein (Ras-GAP) (Veillette et al., 2002) . Immunoblotting with phospho-specific antibodies jointly recognizing Dok-1 and Dok-2 showed that Dok-1 and Dok-2 were indeed hyperphosphorylated in PAG KO T cells ( Figure 6A ). For Dok-1, the increase was prominent in unstimulated T cells and attenuated by TCR stimulation. For Dok-2, the enhancement was minimal in unstimulated T cells and accentuated by TCR stimulation (Figure 6A) . These findings were confirmed by immunoprecipitation ( Figure S5A) .
Immunoblotting of Dok-1 or Dok-2 immunoprecipitates with anti-SHIP-1 or anti-Ras-GAP antibodies revealed that Dok-1 and Dok-2 were more extensively associated with SHIP-1 and Ras-GAP in PAG KO T cells compared with wild-type T cells (Figure 6B ). For Dok-2, this effect was enhanced by TCR stimulation ( Figure 6C ). In addition, Dok-1 was more associated with Csk in PAG KO T cells ( Figure 6B ). Therefore, loss of PAG resulted in enhanced tyrosine phosphorylation of Dok-1 and Dok-2 as well as augmented association of these adaptors with Csk, SHIP-1, and Ras-GAP, three known inhibitory molecules.
Dok Adaptors and SHIP-1 Cooperate with PAG to Inhibit Effector T Cell Responses
To test whether the Dok adaptors might restrict the influence of PAG deficiency, mice lacking both PAG and Dok-1 (PAG Dok-1 DKO) were generated and analyzed together with mice lacking PAG or Dok-1 alone ( Figure S5B ). Like PAG KO T cells, Dok-1 KO T cells displayed enhanced T cell responses in previously activated T cells but not in freshly isolated T cells ( Figure 6D ; Figures S5C and S5D) . However, PAG Dok-1 DKO T cells did not show greater increases in T cell responses than PAG KO or Dok-1 KO T cells ( Figure 6D ; Figures S5C and  S5D ). To probe the involvement of Dok-2, PAG KO T cells or PAG Dok-1 DKO T cells were infected with retroviruses encoding small hairpin RNAs (shRNA) against Dok-2. This resulted in an $80% reduction of Dok-2 expression ( Figure S6A ). Compared with previously activated PAG Dok-1 DKO T cells transduced with scrambled shRNAs, those transduced with Dok-2 shRNAs demonstrated significantly augmented SEB-induced proliferation and IFN-g production ( Figure 6E) . A small increase in TCR-triggered protein tyrosine phosphorylation was also seen ( Figure S6B ). These effects were not seen in Dok-2 shRNA-transduced PAG KO T cells ( Figures S6C and S6D ). These observations implied that loss of both Dok-1 and Dok-2, but not of either adaptor alone, increased the effect of PAG deficiency in previously activated T cells.
Given that SHIP-1 is a prime binding partner of members of the Dok family (Veillette et al., 2002) , we tested the possibility that SHIP-1 was involved in the compensation effected by the Dok adaptors in PAG KO T cells by analyzing PAG SHIP-1 DKO T cells ( Figure S6E ). Previously activated PAG SHIP-1 DKO T cells showed greater SEB-triggered proliferation and cytokine production than PAG KO or SHIP-1 KO T cells ( Figure 6F ). TCR-triggered calcium fluxes, a known target of SHIP-1-mediated inhibition, were also enhanced ( Figure S6F) .
Hence, combined loss of Dok-1 and Dok-2 further enhanced the responses of previously activated PAG KO T cells. A similar effect was seen with loss of SHIP-1, a known effector of Dok-mediated inhibition.
Loss of Cbl Ubiquitin Ligases Enhances Responses in Freshly Isolated T Cells
The finding that PAG deficiency had no appreciable effect on responses in freshly isolated T cells (Dobenecker et al., 2005; Xu et al., 2005 ; this report) implied that alternative mechanisms were responsible for inhibiting TCR signaling in these cells. Although many candidates, such as other PTPs and various ubiquitin ligases, may be involved, we focused on the Cbl ubiquitin ligases, which cause degradation of tyrosine-phosphorylated substrates, in particular ZAP-70 (Huang and Gu, 2008; Thien and Langdon, 1998; Veillette et al., 2002; Zhang et al., 2014) . To test this idea, T cell responses were examined in mice lacking c-Cbl and Cbl-b, the two major Cbl proteins expressed in T cells ( Figure S7A ). Unlike PAG KO mice, c-Cbl Cbl-b DKO mice showed a marked enhancement of TCR-evoked proliferation and IFN-g secretion in freshly isolated T cells compared with wild-type mice ( Figure 7A ). Similar results were obtained with naive CD4 + T cells purified by cell sorting ( Figure S7B ). This was important because c-Cbl Cbl-b DKO mice had a marked increase in the proportion of effector memory T cells at steady state ( Figure S7C ). Significantly, and in contrast, little or no difference in TCR-evoked proliferation and IFN-g secretion was seen in previously activated c-Cbl Cbl-b DKO T cells compared with wild-type T cells ( Figure 7B ).
Freshly isolated, but not previously activated, c-Cbl Cbl-b DKO T cells also displayed a pronounced increase in TCR-triggered protein tyrosine phosphorylation ( Figure 7C ; Figure S7D ). Unlike PAG KO T cells, this effect was restricted to a subset of TCR-regulated substrates, especially p70 and p76. These substrates likely represented ZAP-70 and SLP-76, a known ZAP-70 substrate, as revealed by immunoblotting with phospho-specific antibodies ( Figure 7D ; Figure S7D ).
Interestingly, freshly isolated c-Cbl Cbl-b DKO T cells also displayed increased phosphorylation of Fyn and, to a lesser extent, Lck at their activating tyrosine ( Figure 7D ; Figure S7D ), raising the possibility that the Cbl proteins were also inhibiting, directly or indirectly, the function of Src kinases. Indeed, a previous study has shown that c-Cbl induced degradation of activated Fyn in T cells (Andoniou et al., 2000) . However, because Cbl proteins can behave not only as ubiquitin ligases but also as adaptors (Huang and Gu, 2008; Thien and Langdon, 1998; Veillette et al., 2002; Zhang et al., 2014) , it was possible that the Cbl proteins were also inhibiting Fyn by recruiting Csk. In keeping with this possibility, Csk co-immunoprecipitated with both c-Cbl and Cbl-b ( Figure 7E ). The extent of this association was much greater in TCR-stimulated T cells than in unstimulated T cells.
Therefore, unlike PAG deficiency, loss of Cbl proteins caused increased T cell activation responses in freshly isolated or naive, but not in previously activated, T cells. This effect correlated with augmented tyrosine phosphorylation of selected TCR-regulated substrates, in particular ZAP-70, SLP-76, and Fyn.
DISCUSSION
In this report, we found that PAG has a prominent effect on secondary T cell responses. Previously activated, but not freshly isolated, CD4 + T cells from PAG-deficient mice had increased proliferation and cytokine production in response to anti-TCR complex antibodies, superantigen, or antigen compared with cells from wild-type mice. These alterations were corrected by re-expression of wild-type PAG, but not of a PAG mutant unable to interact with Csk (PAG Y314F), implying that they were likely due to compromised Csk recruitment. PAG KO mice also displayed augmented susceptibility to EAE. Thus, PAG is a critical negative regulator of T cell activation in vitro and in vivo. This role had not been appreciated in earlier studies of PAG KO mice, given that only freshly isolated T cells had been analyzed (Dobenecker et al., 2005; Xu et al., 2005) .
Although a role for PAG in anergy was not recognized in earlier studies of PAG KO mice (Dobenecker et al., 2005; Xu et al., 2005) , our previous studies of transgenic mice overexpressing PAG suggested that PAG promotes T cell anergy (Davidson et al., 2007) , possibly reflecting its ability to inhibit signaling by co-stimulatory receptors, which prevent anergy. Here we observed that loss of PAG markedly reduced anergy induced in vitro by anti-CD3 and in vivo by soluble OVA peptides. The reason why PAG KO mice showed no defect in the anergy models evaluated by the other groups remains to be elucidated.
Previously activated, but not freshly isolated, PAG KO T cells also displayed globally enhanced TCR-triggered protein tyrosine phosphorylation and calcium fluxes compared with wildtype T cells. These effects were accompanied by augmented phosphorylation of the activating tyrosine of the Src kinases Lck and Fyn and were corrected by re-expression of wildtype PAG. Therefore, the increased functional responses of PAG KO T cells were likely due to hyperactive Src kinases, the targets of Csk. However, PAG KO T cells showed little or no appreciable decrease in phosphorylation of the inhibitory tyrosine of Lck (Y505), the immediate target of Csk. Possibly, the pool of TCR-activated Lck, which is regulated by PAG and Csk, is too small to be discriminated from the total pool of Lck. Alternatively, when activated by loss of Y505 phosphorylation in the absence of PAG or Csk, Lck molecules may rapidly re-phosphorylate at Y505. Unlike protein tyrosine phosphorylation and calcium fluxes, PAG KO T cells had little or no enhancement of TCR-mediated activation of downstream effectors such as Erk, Akt, JNK, PKC-q, p38, and IkBa. A similar observation was made with PTPN22 KO T cells (Hasegawa et al., 2004; this report) . In the absence of PAG or PTPN22, a rate-limiting step or negative feedback mechanism may be restricting coupling to these downstream effectors. Interestingly, uncoupling to the Erk pathway was also observed in T cells in which Csk was inactivated pharmacologically (Tan et al., 2014) . It was proposed that the actin cytoskeleton physically restricted coupling of protein tyrosine phosphorylation to the Erk pathway. A related mechanism may be operational in PAG KO or PTPN22 KO T cells.
Compared with wild-type T cells, PAG KO T cells displayed increased association of Csk with its partner PTPN22. This increase might occur because loss of PAG releases a pool of Csk that becomes available to bind PTPN22. Although PAG and PTPN22 interact with distinct domains of Csk (Veillette et al., 2002) , PAG may restrict the accessibility of Csk through steric hindrance, physical competition, conformational modification, or spatial sequestration. There may also be a hierarchy in binding of Csk to its partners, based on their abundance, phosphorylation state, or affinity. Indeed, PAG KO T cells exhibited enhanced tyrosine phosphorylation of Dok-1 and Dok-2 and increased association of these adaptors with Csk and also with SHIP-1 and Ras-GAP. Our observations suggested that PTPN22 and Dok adaptors cooperate with PAG to restrict responses of previously activated T cells. This notion was firmly established by analyses of mice lacking PAG in combination with PTPN22 or Dok adaptors. What is the purpose of having multiple Csk partners to control activation of previously activated T cells? We postulate that this network enables recruitment of Csk to multiple cellular locales, where Src kinases are positioned, and may be needed for efficient control of T cell activation. PAG may recruit Csk to lipid rafts, whereas PTPN22 may bring it to tyrosine-phosphorylated ITAMs and ZAP-70, which are targets of PTPN22 (Cloutier and Veillette, 1996) . Likewise, Dok adaptors may recruit Csk to areas of activation of phosphatidylinositol 3 0 kinase, which triggers recruitment of Dok adaptors by way of their pleckstrin homology domain (Veillette et al., 2002) .
Unlike previously activated PAG KO T cells, there was no increase in T cell responses in freshly isolated PAG KO T cells. A similar phenomenon was observed in PTPN22 KO and Dok-1 KO T cells (Hasegawa et al., 2004; this report) . In the case of PTPN22, only stimulation by weak agonists revealed an effect of PTPN22 deficiency in freshly isolated T cells (Salmond et al., 2014) . Hence, we presume that inhibitors other than PAG, PTPN22, and Dok adaptors are suppressing activation of naive T cells. These inhibitors could provide alternative mechanisms to recruit Csk to the membrane or could even suppress T cell activation independently of Csk.
One candidate for controlling TCR-mediated responses in freshly isolated T cells is the Cbl proteins. Indeed, we observed that c-Cbl Cbl-b DKO mice displayed enhanced activation responses in freshly isolated, but not in previously activated, T cells. This function may relate to the ability of Cbl proteins to cause degradation of key effectors of TCR signaling, such as ZAP-70 and Fyn, or to act as adaptors recruiting other inhibitory molecules, including Csk (Huang and Gu, 2008; Thien and Langdon, 1998; Veillette et al., 2002; Zhang et al., 2014) . In support of the latter idea, we found that Csk co-immunoprecipitated with the Cbl proteins, in particular in TCR-stimulated T cells. In addition to Cbl proteins, it is likely that other Csk-interacting proteins also contribute to inhibition of naive T cells. These notions are compatible with previous studies in which Csk was acutely inhibited in freshly isolated T cells (Tan et al., 2014) . Unlike Cbl deficiency, inactivation of Csk resulted in a more global enhancement of protein tyrosine phosphorylation. Furthermore, it is possible that the network of Csk binding partners might differ between freshly isolated and previously activated T cells.
In summary, our data provide evidence that PAG is a critical negative regulator of TCR signaling and T cell activation in effector T cells. This function seemingly relates to the ability of PAG to recruit Csk to the plasma membrane, where Src kinases are located. In this function, PAG cooperates with other Csk-interacting proteins; namely, PTPN22 and Dok adaptors. In contrast, PAG has no appreciable role in naive T cells, likely because of the ability of other negative regulators, including the Cbl proteins, to control TCR signaling in these cells. The involvement of PAG in the control of effector T cell activation may be crucial to enable faster suppression of effector T cell responses compared with naive T cell responses. Given their role in the control of effector T cell activation, it is also attractive to speculate that not only PTPN22, as reported previously (Bottini and Peterson, 2014) , but also PAG and Dok adaptors may be implicated in the pathogenesis of disorders involving repeated or sustained T cell responses in humans, such as autoimmunity. ; Cd4-Cre; Cblb À/À ) have been described elsewhere (Davidson et al., 2003; Kitaura et al., 2007; Lindquist et al., 2011; Tarasenko et al., 2007; Yang and Seed, 2003) . Mice expressing the Cre recombinase under the control of the CD4 promoter (Cd4-Cre) were from Taconic. Transgenic mice expressing MHC class II-restricted TCR OT-II or AND were also reported (Barnden et al., 1998; Kaye et al., 1989) . All mice were maintained in the C57BL/6 background. Littermates were used as controls in all experiments. Animal experimentation was done in accordance with the Canadian Council of Animal Care and approved by the Institut de recherches cliniques de Montré al (IRCM) Animal Care Committee.
Cells
Freshly isolated CD4
+ T cells were obtained from the spleen using a purification kit (STEMCELL Technologies) or a Dynabead CD4 + T cell enrichment kit (Thermo Fisher Scientific). Cell purity was consistently greater than 90% (data not shown). In some experiments, naive CD4 + T cells were purified by cell sorting. Purity was greater than 99%. Previously activated CD4 + T cells were generated by stimulating purified cells with anti-CD3 (3 mg/mL) immobilized on plastic and soluble anti-CD28 (1 mg/mL) for 2 days and then expansion in IL-2 (50 units/mL) for 3 days.
T Cell Activation Assays CD4 + T cells were activated with anti-CD3 or anti-TCR with or without anti-CD28. For stimulation with superantigen, CD4 + T cells were incubated with the indicated concentrations of SEB (Sigma-Aldrich) in the presence of irradiated splenocytes from C57BL/6 mice. For stimulation with antigenic peptides, T cells were activated with the indicated concentrations of OVA peptide (323-339) or PCC peptide (88-104) in the presence of irradiated splenocytes from C57BL/6 or B10.BR mice, respectively. As a control, cells were activated with PMA (100 ng/ml) and ionomycin (1 mM). Proliferation was measured by [ 3 H]-thymidine incorporation, and cytokine production was assessed by ELISA (R&D Systems). All assays were done in triplicate.
Immunization with Ovalbumin
Mice were immunized in the foot pad with OVA protein (100 mg, SigmaAldrich) in the presence of complete Freund adjuvant (CFA, Sigma-Aldrich). After 9 days, CD4 + T cells were isolated from popliteal lymph nodes and re-stimulated in vitro with the indicated concentrations of OVA and irradiated splenocytes or with P+I. Proliferation and cytokine production were determined.
Biochemical Assays
Cells were stimulated for the indicated times at 37 C with biotinylated anti-CD3 or anti-TCR, with or without anti-CD28, and avidin. After lysis in maltoside-containing buffer supplemented with protease and phosphatase inhibitors, lysates were processed for immunoprecipitation or immunoblotting (Davidson et al., 2003 (Davidson et al., , 2007 (Davidson et al., , 2010 . Quantification of blots was performed with ImageJ software.
EAE
Mice were injected sub-cutaneously with MOG peptide 35-55 in CFA plus Mycobacterium tuberculosis H37Ra (Difco Laboratories), followed 24 and 72 hr later by injection of pertussis toxin as described (Davidson et al., 2010) . In some experiments, a booster was administered on day 35. Mice were scored regularly for neurological deficits as follows: 0, no clinical signs; 1, loss of tail tonicity; 2, flaccid tail; 3, hindleg paralysis; 4, hindleg paralysis with hindbody paresis; 5, hind-and foreleg paralysis. After 6 weeks, splenic CD4 + T cells were re-stimulated in vitro with MOG peptide plus irradiated splenocytes or with P+I. For adoptive transfer, CD4 + T cells from MOG-immunized mice were purified 10 days after immunization and re-stimulated in vitro with MOG peptide plus irradiated splenocytes in the presence of IL-23 (10 ng/mL) and anti-IFN-g (10 mg/mL) to expand MOG-specific T H 17 cells. After 5 days, T cells were injected into RAG-1 KO mice. 24 hr later, pertussis toxin was injected into the recipient mice. The mice were then monitored for EAE.
Statistical Analyses
Prism 6 software was used for unpaired or paired Student's t tests (two-tailed), non-parametric Wilcoxon matched-pairs t test, or one-way ANOVA followed by Tukey's or Dunnett's multiple comparison test when appropriate.
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